AstraZeneca's Brilinta ByS. Alexander Winans, PharmD,Laura M. Challen, PharmD, BCPS, MBANovember 9th 2011The FDA approved Brilinta (ticagrelor) for reducing the rate of thrombotic cardiovascular events in patients with acute coronary syndrome when taken with aspirin.